Evidence map›Paper›PMID 18204829›Full record

ArticleDiabetologia2008

Isoform-specific defects of insulin stimulation of Akt/protein kinase B (PKB) in skeletal muscle cells from type 2 diabetic patients.

D Cozzone, S Fröjdö, E Disse, C Debard, M Laville, L Pirola, H Vidal

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Diabetologia, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 98 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. A Novel Blend ofFoods (Basel, Switzerland) · 2026
    Article
  5. Article
  6. Article
  7. Circadian Clock Desynchronization and Insulin Resistance.International journal of environmental research and public health · 2022
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. PHLPP Signaling in Immune Cells.Current topics in microbiology and immunology · 2022
    Review
  14. AKT ISOFORMS-AS160-GLUT4: The defining axis of insulin resistance.Reviews in endocrine & metabolic disorders · 2021
    Review
  15. Role of Akt isoforms in neuronal insulin signaling and resistance.Cellular and molecular life sciences : CMLS · 2021
    Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

D CozzoneINSERM, U-870, IFR62, Faculté de Médecine Lyon Sud, Chemin du Grand Revoyet, F-69600 Oullins, France.
S Fröjdö
E Disse
C Debard
M Laville
L Pirola
H Vidal
Université Claude Bernard Lyon 1 · FRHospices Civils de Lyon · FRInserm · FRInstitut National des Sciences Appliquées de Lyon · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aims/hypothesisThe serine/threonine kinase Akt/protein kinase B (PKB) is required for the metabolic actions of insulin. Controversial data have been reported regarding Akt defective activation in the muscle of type 2 diabetic patients. Because three Akt isoforms exist, each having a distinct physiological role, we investigated the contribution of isoform-specific defects to insulin signalling in human muscle.

methodsThe phosphorylation pattern and kinase activity of each Akt isoform were compared in primary myotubes from healthy control participants and type 2 diabetic patients. Phosphorylation of Ser(473) and of Thr(308) in each isoform was determined after immunoprecipitation in myotubes treated or not with insulin.

resultsMuscle cells from diabetic patients displayed defective insulin action and a drastic reduction of insulin-stimulated activity of all Akt isoforms. This was associated with specific defects of their phosphorylation pattern in response to insulin, with impaired Akt2- (and to a lower extent Akt3-) Ser(473) phosphorylation, and with altered Akt1-Thr(308) phosphorylation. These defects were not due to faulty phosphoinositide-dependent protein kinase 1 (PDK1) production or activation. Rather, we found higher levels of the Akt2-Ser(473)-specific protein phosphatase PH domain leucine-rich repeat protein phosphatase 1 (PHLPP1) in muscle from diabetic patients, which may contribute to the alteration of Akt2-Ser(473) phosphorylation. CONCLUSIONS/

interpretationThese results suggest that several mechanisms affecting Akt isoforms, including deregulated production of PHLPP1, could underlie the alterations of skeletal muscle insulin signalling in type 2 diabetes. Taking into account the recently described isoform-specific metabolic functions of Akt, our results provide mechanistic insight that may contribute to the defective regulation of glucose and lipid metabolisms in the muscle of diabetic patients.

Indexed as

AdultDiabetes Mellitus, Type 2Enzyme ActivationFemaleHumansInsulinIsoenzymesMaleMiddle AgedMuscle, SkeletalNuclear ProteinsPhosphoprotein PhosphatasesPhosphorylationPhosphoserinePhosphothreonineProto-Oncogene Proteins c-aktInsulinIsoenzymesNuclear ProteinsPHLPP1 protein, humanPhosphoprotein PhosphatasesPhosphoserinePhosphothreonineProto-Oncogene Proteins c-aktRNA, Messenger

Identifiers

PMID18204829
OpenAlexW2002047357

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.